Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
Subscribe To Our Newsletter & Stay Updated
